Back to Search
Start Over
Initiation of new psychotropic prescriptions without a psychiatric diagnosis among US adults: Rates, correlates, and national trends from 2006 to 2015
- Source :
- Health Services Research. February, 2019, Vol. 54 Issue 1, p139, 10 p.
- Publication Year :
- 2019
-
Abstract
- Objectives: To estimate rates and national trends of initiation of new psychotropic medications without a psychiatric diagnosis and to identify demographic and clinical correlates independently associated with such use among US adults in outpatient settings.Data Source: Data were gathered from the 2006-2015 National Ambulatory Medical Care Survey (NAMCS), a nationally representative sample of office-based U.S. outpatient care. The sample was limited to adults aged 18 or older who received a new psychotropic drug prescription (n = 8618 unweighted).Study Design: Using a repeated cross-sectional design with survey sampling techniques, we estimated prescription initiation rates and national trends. Multivariable-adjusted logistic regression analysis was used to identify correlates independently associated with initiation of new psychotropic prescriptions without a psychiatric diagnosis.Data Collection/Extraction Methods: Data were publicly available, and we extracted them from the Centers for Disease Control and Prevention website.Principal Findings: Altogether, at 60.4% of visits at which a new psychotropic prescription was initiated, no psychiatric diagnosis was recorded for the visit. Overall, the rate increased from 59.1% in 2006-2007 to 67.7% in 2008-2009 and then decreased to 52.0% in 2014-2015. Visits to psychiatrists were associated with very low odds of having no psychiatric diagnosis when compared to primary care visits (OR = 0.02; 95% CI, 0.01-0.04). Visits to non-psychiatric specialists showed 6.90 times greater odds of not having a psychiatric diagnosis when compared to primary care visits (95% CI, 5.38-8.86).Conclusion: New psychotropic medications are commonly initiated without any psychiatric diagnosis, especially by non-psychiatrist physicians. Non-psychiatrists should document relevant diagnoses more vigilantly to prevent potentially inappropriate use or misuse.KEYWORDSprescribing patterns, prescription, psychiatric diagnosis, psychotropic<br />1 | INTRODUCTIONThe use of prescription psychotropic medications has increased steadily over the past two decades, (1-4) driven, in large part, by the increased prescribing of these medications by non-psychiatrists. [...]
- Subjects :
- United States. Food and Drug Administration -- Analysis
Patient care -- Analysis
Adults -- Surveys -- Analysis
Health surveys -- Analysis
Medical schools -- Analysis
Medical research -- Analysis
Psychotropic drugs -- Analysis
Ambulatory care
Physicians
Regression analysis
Psychiatrists
Business
Health care industry
Yale University. School of Medicine
Subjects
Details
- Language :
- English
- ISSN :
- 00179124
- Volume :
- 54
- Issue :
- 1
- Database :
- Gale General OneFile
- Journal :
- Health Services Research
- Publication Type :
- Periodical
- Accession number :
- edsgcl.574566618
- Full Text :
- https://doi.org/10.1111/1475-6773.13072